Anna Svystak

Anna Svystak

Auto-generated profile, based on publicly available information

Anna Svystak

Department of Dermatology, Dr. Bogomolets Institute of Dermatology and Cosmetology, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
OBOlga Bogomolets
Olga Bogomolets
RHRoman Hryshchenko
Roman Hryshchenko
OBOleksandr Berezkin
Oleksandr Berezkin
SBSofiia Bogomolets-Sheremetieva
Sofiia Bogomolets-Sheremetieva
ASAnna Svystak
Anna Svystak
Rosai–Dorfman disease (RDD) is a rare non-Langerhans cell histiocytosis that typically presents with massive cervical lymphadenopathy and systemic manifestations. The cutaneous form is usually limited to the skin and rarely progresses to systemic involvement. Timely confirmation of the diagnosis of RDD in cases of progression to systemic involvement is a challenge for the health care system. We report a 23-year-old woman with a history of COVID-19 infection and subsequent mRNA vaccination who developed acneiform eruptions on her face and at the vaccination site on her shoulder. Biopsies confirmed cutaneous RDD without lymphadenopathy. After more than one year of a purely cutaneous course, she developed cough and dyspnea. Imaging revealed an isolated bronchial lesion without lymph node involvement; histology confirmed RDD. The patient responded to local corticosteroid injections and systemic glucocorticoids, with stabilization of the disease. Our report underscores the importance of considering RDD in persistent acneiform eruptions unresponsive to treatment and bronchial masses without lymphadenopathy.